🧬 "Be On It”: High-Stakes Deals & Building World-Class Teams | Sujal Patel (Part 3/4)
Episode
35 min
Read time
2 min
Topics
Relationships, Investing, Startups
AI-Generated Summary
Key Takeaways
- ✓Acquisition negotiation posture: When a buyer presents an offer, train yourself to respond with "I have no reaction — my responsibility is to take this to the board." Repeat this answer regardless of how many times they press. This removes emotional leverage from the buyer and prevents premature anchoring before board consultation, a tactic Patel used successfully against EMC's $25/share opening offer.
- ✓Competitive leverage in M&A: Actively build relationships with competing acquirers — NetApp, Dell, others — while in parallel OEM discussions. Patel scheduled a NetApp meeting the same day as EMC's Pat Gelsinger dinner, requiring a private jet to make both. Visible competition between buyers drove Isilon's price from an initial $25/share offer toward a final $33.85/share executed agreement.
- ✓Talent acquisition speed: When a high-value candidate becomes available, act within hours, not days. Patel called Leonard Ivan Tosh — a channels executive at rival NetApp — while he was still in the parking lot with his desk belongings. That same-day call led to an immediate hire who rebuilt Isilon's indirect distribution program before the EMC acquisition closed.
- ✓Expanded product-market fit framework: Traditional product-market fit covers roughly 33% of what startups need. The remaining 66% involves whether you can manufacture at scale, sell cost-effectively, shorten sales cycles, and defend against competitive displacement. Patel applied this lens to 80 private investments and used it to narrow Isilon's go-to-market from seven verticals to five before expanding to general purpose.
- ✓Post-acquisition structural preservation: Before signing, negotiate reporting structure and operational independence explicitly. Patel refused to report to the acquiring division head, escalated directly to Pat Gelsinger, and ultimately convinced EMC CEO Joe Tucci to keep Isilon as a standalone unit rather than merging it. That decision protected the product line, which has since generated over $25 billion in lifetime revenue inside Dell.
What It Covers
Sujal Patel recounts the high-stakes acquisition of Isilon by EMC, detailing months of OEM pretense negotiations, a Saturday phone negotiation that landed at $33.85 per share, post-acquisition leadership decisions that preserved $25 billion in lifetime revenue, and the founding of Nautilus Biotechnology with co-founder Parag Malik in 2016.
Key Questions Answered
- •Acquisition negotiation posture: When a buyer presents an offer, train yourself to respond with "I have no reaction — my responsibility is to take this to the board." Repeat this answer regardless of how many times they press. This removes emotional leverage from the buyer and prevents premature anchoring before board consultation, a tactic Patel used successfully against EMC's $25/share opening offer.
- •Competitive leverage in M&A: Actively build relationships with competing acquirers — NetApp, Dell, others — while in parallel OEM discussions. Patel scheduled a NetApp meeting the same day as EMC's Pat Gelsinger dinner, requiring a private jet to make both. Visible competition between buyers drove Isilon's price from an initial $25/share offer toward a final $33.85/share executed agreement.
- •Talent acquisition speed: When a high-value candidate becomes available, act within hours, not days. Patel called Leonard Ivan Tosh — a channels executive at rival NetApp — while he was still in the parking lot with his desk belongings. That same-day call led to an immediate hire who rebuilt Isilon's indirect distribution program before the EMC acquisition closed.
- •Expanded product-market fit framework: Traditional product-market fit covers roughly 33% of what startups need. The remaining 66% involves whether you can manufacture at scale, sell cost-effectively, shorten sales cycles, and defend against competitive displacement. Patel applied this lens to 80 private investments and used it to narrow Isilon's go-to-market from seven verticals to five before expanding to general purpose.
- •Post-acquisition structural preservation: Before signing, negotiate reporting structure and operational independence explicitly. Patel refused to report to the acquiring division head, escalated directly to Pat Gelsinger, and ultimately convinced EMC CEO Joe Tucci to keep Isilon as a standalone unit rather than merging it. That decision protected the product line, which has since generated over $25 billion in lifetime revenue inside Dell.
Notable Moment
After EMC walked away from the deal at $32.50/share on a Friday afternoon, Patel rejected the fully executed merger agreement sent by fax. The following Saturday, during a tight phone negotiation, he requested $34, was told that specific number was off-limits, and landed on $33.85 — a $5 million difference in total consideration.
You just read a 3-minute summary of a 32-minute episode.
Get The Biotech Startups Podcast summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from The Biotech Startups Podcast
🧬 From Games to Cancer Research: Why Drug Discovery Is an Economics Problem | Javier Tordable (3/4)
Jul 27 · 22 min
Dwarkesh Podcast
I’m glad the Anthropic fight is happening now
Mar 11
More from The Biotech Startups Podcast
🧬 16 Years at Google Taught Me How to Scale From 1 to 150 People | Javier Tordable (2/4)
Jul 23 · 28 min
The Rich Roll Podcast
Michelle Khare Is The Tom Cruise Of YouTube: How Anxiety Became Her Superpower
Jul 27
More from The Biotech Startups Podcast
We summarize every new episode. Want them in your inbox?
🧬 From Games to Cancer Research: Why Drug Discovery Is an Economics Problem | Javier Tordable (3/4)
🧬 16 Years at Google Taught Me How to Scale From 1 to 150 People | Javier Tordable (2/4)
🧬 Video Games & a Whim Led Me to Microsoft | Javier Tordable (1/4)
🧬 Crossover Investing, Gene Therapy & LP Trust | Stephanie Sirota Rerelease (3/3)
🧬 Cycles, Conviction & Royalty Capital in Biotech Investing | Stephanie Sirota Rerelease (2/3)
Similar Episodes
Related episodes from other podcasts
Dwarkesh Podcast
Mar 11
I’m glad the Anthropic fight is happening now
The Rich Roll Podcast
Jul 27
Michelle Khare Is The Tom Cruise Of YouTube: How Anxiety Became Her Superpower
The Daily (NYT)
Jul 15
From Trump’s Attorney to Attorney General: The Rise of Todd Blanche
Eye on AI
Jul 10
What Industrial AI Actually Looks Like | Kriti Sharma, Nexus Black
The Vergecast
Jun 19
Version History: Harmony remote
Explore Related Topics
This podcast is featured in Best Science Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Investing & Markets Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into The Biotech Startups Podcast.
Every Monday, we deliver AI summaries of the latest episodes from The Biotech Startups Podcast and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime